It has not yet been tested for AD, but in a chemical lesion of the nucleus magnocellularis ATROSAB prevented microglial activation and shifted TNF signaling toward TNFR2, potentiating the neuroprotective pathways [229]. The gene discussed is TNFRSF1B; the disease is Alzheimer disease.